Details for New Drug Application (NDA): 018893
✉ Email this page to a colleague
The generic ingredient in SODIUM ACETATE is sodium acetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sodium acetate profile page.
Summary for 018893
Tradename: | SODIUM ACETATE |
Applicant: | Hospira |
Ingredient: | sodium acetate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 018893
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 018893
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM ACETATE | sodium acetate | SOLUTION;INTRAVENOUS | 018893 | NDA | Hospira, Inc. | 0409-3299 | 0409-3299-25 | 25 VIAL in 1 CASE (0409-3299-25) / 100 mL in 1 VIAL (0409-3299-45) |
SODIUM ACETATE | sodium acetate | SOLUTION;INTRAVENOUS | 018893 | NDA | Hospira, Inc. | 0409-3299 | 0409-3299-26 | 25 VIAL in 1 TRAY (0409-3299-26) / 50 mL in 1 VIAL (0409-3299-46) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 40MEQ/20ML (2MEQ/ML) | ||||
Approval Date: | May 4, 1983 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MEQ/50ML (2MEQ/ML) | ||||
Approval Date: | Sep 2, 2014 | TE: | AP | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 200MEQ/100ML (2MEQ/ML) | ||||
Approval Date: | Sep 2, 2014 | TE: | AP | RLD: | Yes |
Complete Access Available with Subscription